Abstract
IntroductionMyasthenia gravis (MG) is a T cell-dependent B cell-mediated autoimmune disease with pathogenic antibodies directed against components of the acetylcholine receptor (AChR). Current therapies do not address the root cause...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have